Who are Short ragweed pollen allergen extract's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): RAGWEED 12 AMB A 1-U, Penicillin skin test kit.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/short-ragweed-pollen-allergen-extract.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Short ragweed pollen allergen extract — Competitive Intelligence Brief

Short ragweed pollen allergen extract (Short ragweed pollen allergen extract) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: allergen extract. Area: Immunology.

phase 3 allergen extract Immunology Biologic Live · refreshed every 30 min

Target snapshot

Short ragweed pollen allergen extract (Short ragweed pollen allergen extract) — Merck Sharp & Dohme LLC. Short ragweed pollen allergen extract works by desensitizing patients to short ragweed pollen through subcutaneous injections.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Short ragweed pollen allergen extract TARGET	Short ragweed pollen allergen extract	Merck Sharp & Dohme LLC	phase 3	allergen extract
RAGWEED 12 AMB A 1-U	RAGWEED 12 AMB A 1-U	Clinique Spécialisée en Allergies de la Capitale	marketed	Allergen extract immunotherapy	Ragweed pollen allergens (Amb a 1 and related epitopes)
Penicillin skin test kit	Penicillin skin test kit	AllerQuest LLC	phase 3	Diagnostic test kit / Allergen extract

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (allergen extract class)

Merck Sharp & Dohme LLC · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Short ragweed pollen allergen extract — Competitive Intelligence Brief. https://druglandscape.com/ci/short-ragweed-pollen-allergen-extract. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab